A recent DGIST study shows somatostatin overexpression reduces inflammation and amyloid β in mice, suggesting repurposing existing drugs like octreotide could accelerate Alzheimer’s therapy and...
New research reveals APOE ε3 and ε4 variants are implicated in most Alzheimer’s cases, sparking debates on genetic screening, lifestyle changes, and gene therapy in prevention strategies. A gr...
Recent studies identify FOXF2 and TIE2 as key genetic regulators in cerebral small vessel disease, with AKB-9778 showing promise in clinical trials for enhancing vascular health and cognitive function...
